Viewing Study NCT07031258


Ignite Creation Date: 2025-12-25 @ 12:00 AM
Ignite Modification Date: 2026-01-25 @ 11:08 AM
Study NCT ID: NCT07031258
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-06-22
First Post: 2025-05-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Evaluation of the Efficacy of Darolutamide Triplet Therapy in Patients With Metastatic Hormone-sensitive Prostate Cancer
Sponsor: Nanfang Hospital, Southern Medical University
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: NFEC-2025-218
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators